However, there were no changes in the level of the Th2 cytokine IL‐4 in any of the groups (Figure 5k), suggesting that immunization with SyBV primes a tEV‐driven tumour‐specific Th1 immune response. The gene discussed is IL4; the disease is neoplasm.